30/07/2021
BDR Pharma, in sight of the 3rd wave of COVID-19, gears up! We have inked a licensing deal with the Defence Research and Development Organisation (DRDO) to manufacture and sell a COVID drug, 2-Deoxy-D-Glucose, in the country. Follow this link to know more about the drug and hear the thoughts of Mr Dharmesh Shah, Chairman of BDR Pharma, on the development.
BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country.